01 2Nomisma Healthcare
01 2Tablet
01 2India
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : PLGA-PEG
Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Grade : Oral, Parenteral
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.
Ingredient(s) : Poly DL Lactide co Glycolide
Dosage Form : Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly DL Lactide co Glycolide
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : PLGA
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.
Grade : Oral, Parenteral
LOOKING FOR A SUPPLIER?